IDEXX Laboratories Inc (IDXX) Receives Neutral Rating from UBS
UBS initiates coverage on IDEXX Laboratories Inc with a Neutral rating.
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
Latest news, analyst ratings, earnings reports, dividends, insider trades, and market analysis for IDEXX Laboratories Inc.
Last Updated: Dec 11, 2025, 11:07 PM · Source: Finnhub.io
UBS initiates coverage on IDEXX Laboratories Inc with a Neutral rating.
Stifel has upgraded IDEXX Laboratories Inc (IDXX) to Buy from Hold.
IDEXX Laboratories Inc (IDXX) posts Q3 2025 earnings that surpass expectations.